Dr Lal Pathlabs Ltd

Dr Lal Pathlabs Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Dr Lal Pathlabs Ltd

₹ 1,698 3.16%
19 May 4:01 p.m.
lalpathlabs.com BSE: 539524 NSE: LALPATHLAB
About

Dr. Lal PathLabs Limited is one of India’s leading consumer healthcare brand in diagnostic services. It has an integrated nationwide network, where patients and healthcare providers are offered a broad range of diagnostic and related healthcare tests and services for use in: core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. The services of DLPL are aimed at individual patients, hospitals and other healthcare providers and corporates. [1]

Key Points

Largest Diagnostic Chain
It is the largest diagnostics chain with a Pan-India presence. The company has 75 years of experience in the field of diagnostics and has served 131 million patients in the last five years. Its test offerings range from basic preventive health packages like SwasthFit to the most advanced investigations, including Comprehensive Genomic Profiles, Myeloid testing for Hematological Malignancies, and Amyloid Typing Solutions. [1] [2]

Website BSE NSE
  • Market Cap ₹ 28,473 Cr.
  • Current Price ₹ 1,698
  • High / Low ₹ 1,771 / 1,272
  • Stock P/E 54.0
  • Book Value ₹ 150
  • Dividend Yield 0.83 %
  • ROCE 28.3 %
  • ROE 22.5 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.

Cons

  • Stock is trading at 11.3 times its book value
  • The company has delivered a poor sales growth of 11.8% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Healthcare Service Provider

Part of BSE 500 BSE Healthcare Nifty 500 Nifty Smallcap 100 BSE SmallCap Select Index

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
491 541 601 539 545 602 660 597 603 670 731 660 703
375 395 424 398 401 432 458 443 434 478 506 480 516
Operating Profit 116 146 178 141 145 170 202 154 169 192 224 179 187
OPM % 24% 27% 30% 26% 27% 28% 31% 26% 28% 29% 31% 27% 27%
14 14 18 18 18 21 22 25 26 28 25 -6 24
Interest 9 8 8 7 7 6 6 5 5 5 5 7 6
Depreciation 38 35 36 36 37 35 35 36 36 35 40 42 45
Profit before tax 83 118 152 116 120 150 183 138 153 181 204 124 160
Tax % 32% 29% 27% 29% 28% 28% 29% 29% -1% 26% 25% 26% 17%
57 84 111 82 86 108 131 98 156 134 152 91 132
EPS in Rs 3.40 4.95 6.55 4.87 5.06 6.37 7.73 5.78 9.26 7.90 8.99 5.40 7.84
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
660 791 912 1,057 1,203 1,330 1,581 2,087 2,017 2,227 2,461 2,763
504 582 675 793 910 987 1,145 1,526 1,527 1,617 1,764 1,980
Operating Profit 156 210 238 264 294 344 436 561 490 609 698 782
OPM % 24% 26% 26% 25% 24% 26% 28% 27% 24% 27% 28% 28%
12 20 27 31 46 55 51 52 42 69 91 71
Interest 0 0 1 1 1 15 16 30 38 29 22 23
Depreciation 28 28 28 33 38 73 77 108 150 144 142 162
Profit before tax 140 201 237 261 301 310 394 475 344 505 625 669
Tax % 31% 34% 34% 34% 33% 27% 25% 26% 30% 28% 21% 24%
96 133 156 172 200 228 296 350 241 362 492 510
EPS in Rs 8.75 7.99 9.31 10.24 11.95 13.55 17.49 20.69 14.33 21.42 29.14 30.13
Dividend Payout % 9% 15% 16% 22% 25% 44% 57% 29% 42% -0% -0% 81%
Compounded Sales Growth
10 Years: 13%
5 Years: 12%
3 Years: 11%
TTM: 12%
Compounded Profit Growth
10 Years: 15%
5 Years: 13%
3 Years: 30%
TTM: 8%
Stock Price CAGR
10 Years: 13%
5 Years: 3%
3 Years: 19%
1 Year: 18%
Return on Equity
10 Years: 23%
5 Years: 22%
3 Years: 22%
Last Year: 23%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 55 83 83 83 83 83 83 83 83 83 84 168
Reserves 260 425 512 705 862 949 1,162 1,418 1,583 1,766 2,089 2,341
27 -0 -0 -0 -0 -0 150 533 420 247 157 199
134 118 95 128 145 341 265 309 297 357 383 439
Total Liabilities 475 625 690 916 1,091 1,374 1,661 2,343 2,383 2,454 2,713 3,146
150 166 152 208 209 413 447 1,369 1,305 1,228 1,168 1,257
CWIP 1 4 18 10 3 11 10 15 5 6 3 6
Investments 38 64 106 145 185 164 59 65 150 114 327 423
286 391 414 554 694 786 1,144 893 923 1,107 1,215 1,461
Total Assets 475 625 690 916 1,091 1,374 1,661 2,343 2,383 2,454 2,713 3,146

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
122 159 171 197 219 284 398 447 456 535 569 636
-113 -163 -137 -172 -100 -26 -212 -449 -287 -24 -303 -422
-1 0 -32 13 -55 -190 -139 136 -283 -414 -334 -264
Net Cash Flow 8 -5 2 37 64 67 48 134 -114 97 -68 -50
Free Cash Flow 87 115 120 125 177 205 339 -28 412 479 516 463
CFO/OP 112% 108% 102% 110% 110% 110% 115% 103% 115% 110% 105% 104%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 17 17 17 14 16 14 15 15 13 13 13 15
Inventory Days 37 31 33 44 40 70 39 38 28 30 27 30
Days Payable 90 89 97 106 111 144 132 107 127 151 151 123
Cash Conversion Cycle -35 -42 -47 -47 -55 -60 -78 -54 -87 -108 -110 -79
Working Capital Days -9 27 19 17 0 -19 -26 -54 -56 -46 -30 27
ROCE % 48% 47% 43% 38% 35% 32% 33% 29% 18% 25% 29% 28%

Insights

In beta
Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Number of Patients Served (Organic)
Million

Log in to view insights

Please log in to see hidden values.

Login
Realization per Patient
INR

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

12 Recently
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
55.01% 54.61% 54.60% 54.60% 54.60% 53.92% 53.91% 53.91% 53.79% 53.21% 53.21% 53.21%
23.27% 24.35% 25.36% 26.15% 25.43% 26.82% 26.82% 23.90% 21.69% 21.86% 20.29% 17.18%
8.34% 8.85% 9.27% 9.40% 12.42% 12.60% 12.88% 15.79% 17.62% 18.22% 19.20% 21.37%
0.29% 0.29% 0.29% 0.29% 0.29% 0.29% 0.29% 0.29% 0.29% 0.27% 0.01% 0.01%
12.65% 11.48% 10.12% 9.24% 6.95% 6.02% 5.82% 5.84% 6.22% 6.07% 6.94% 7.88%
0.44% 0.41% 0.37% 0.32% 0.30% 0.33% 0.28% 0.27% 0.39% 0.37% 0.35% 0.34%
No. of Shareholders 1,74,4441,60,6791,49,9011,46,7411,31,1891,16,6061,16,2361,15,6991,18,6561,12,7031,16,1671,14,527

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls